Abstract
A druggable proteome is of global interest for the drug development process. Growing livestock for food relies strongly on pharmacologically active chemicals, or medicines, in modern agricultural practice. The use of medications in food animals is critical for the welfare and well-being of the animals and the industry’s economics. Drug consumption, on the other hand, is linked to adverse impacts on public well-being. Therefore it is crucial to test the drug comprehensively before its use in agricultural practice. The identification of druggable proteome requires a non-trivial amount of resources and time, therefore, artificial intelligence and machine learning have emerged as invaluable tools for drawing meaningful perspectives and improving decision making in drug research. In this respect, the overall drug discovery process necessitates a long-term transition and lowers production costs. Artificial intelligence is a promising alternative for dysfunctional drug discovery and development. This chapter outlines the applications of artificial intelligence and machine learning innovations to many other techniques in drug development, such as target recognition, compound screening, lead generation and optimization, drug reaction and synergy prediction, de novo drug design, and drug repurposing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- SMILES:
-
Simplified Molecular Input Line Entry System
- DTA:
-
Drug-Target binding Affinity
- DTI:
-
Drug-Target protein Interaction
References
Acharya A, Garg LC (2016) Drug target identification and prioritization for treatment of ovine foot rot: an In Silico approach. Int J Genomics 2016:7361361
Ali SA, Singh P, Tomar SK, Mohanty AK, Behare P (2020) Proteomics fingerprints of systemic mechanisms of adaptation to bile in Lactobacillus fermentum. J Proteome 213:103600
Almeida AM, Ali SA, Ceciliani F, Eckersall PD, Hernandez-Castellano LE, Han R, Hodnik JJ, Jaswal S, Lippolis JD, McLaughlin M, Miller I (2021) Domestic animal proteomics in the 21st century: a global retrospective and viewpoint analysis. J Proteome 241:104220
Baxevanis AD, Bateman A (2015) The importance of biological databases in biological discovery. Curr Protoc Bioinformatics 50(1):1–1
Bender A, Cortes-Ciriano I (2020) Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: ways to make an impact, and why we are not there yet. Drug Discov Today. https://doi.org/10.1016/j.drudis.2020.12.009
Bender A, Cortes-Ciriano I (2021) Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data used for AI in drug discovery. Drug Discov Today 26:511–524
Blaschke T, Olivecrona M, Engkvist O, Bajorath J, Chen H (2018) Application of generative autoencoder in de novo molecular design. Mol Inf 37(1–2):1700123
Boby N, Abbas MA, Lee EB, Park SC (2020) Pharmacodynamics of Ceftiofur selected by genomic and proteomic approaches of streptococcus parauberis isolated from the flounder, Paralichthys olivaceus. Int J Genomics 2020:4850290
Briken V (2008) Molecular mechanisms of host-pathogen interactions and their potential for the discovery of new drug targets. Curr Drug Targets 9(2):150–157
Chopra A, Ali SA, Bathla S, Rawat P, Vohra V, Kumar S, Mohanty AK (2020) High-resolution mass spectrometer–based ultra-deep profile of milk whey proteome in Indian Zebu (Sahiwal) cattle. Front Nutr 7:150
Cohen P (2002) Protein kinases—the major drug targets of the twenty-first century? Nat Rev Drug Discov 1(4):309–315
Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 29:1046–1051
Dykstra C, Frenking G, Kim K, Scuseria G (eds) (2011) Theory and applications of computational chemistry: the first forty years. Elsevier
Entzeroth M, Flotow H, Condron P (2009) Overview of high-throughput screening. Curr Protoc Pharmacol 44(1):9–4
Gashaw I, Ellinghaus P, Sommer A, Asadullah K (2011) What makes a good drug target? Drug Discov Today 16(23–24):1037–1043
Geoffrey B, Sanker A, Madaj R, Tresanco MSV, Upadhyay M, Gracia J (2020) A program to automate the discovery of drugs for West Nile and Dengue virus—programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling. J Biomol Struct Dyn 40:1–9
Géron A (2019) Hands-on machine learning with Scikit-learn, Keras, and TensorFlow: concepts, tools, and techniques to build intelligent systems. O’Reilly Media
Gollapudi S (2016) Practical machine learning. Packt Publishing Ltd
Govindaraj RG, Brylinski M (2018) Comparative assessment of strategies to identify similar ligand-binding pockets in proteins. BMC Bioinf 19(1):1–17
Gupta A, Müller AT, Huisman BJH, Fuchs JA, Schneider P, Schneider G (2018) Generative recurrent networks for de novo drug design. Mol Inf 37(1–2):1700111
Hassan SS, Tiwari S, Guimarães LC, Jamal SB, Folador E, Sharma NB, de Castro Soares S, Almeida S, Ali A, Islam A, Póvoa FD (2014) Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics 15(7):1–19
He T, Heidemeyer M, Ban F, Cherkasov A, Ester M (2017) SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines. J Cheminformatics. https://doi.org/10.1186/s13321-017-0209-z
Honda S, Shi S, Ueda HR (2019) SMILES transformer: pre-trained molecular fingerprint for low data drug discovery. CoRR
Huang K, Xiao C, Glass LM, Sun J (2020) MolTrans: molecular interaction transformer for drug–target interaction prediction. Bioinformatics. https://doi.org/10.1093/bioinformatics/btaa880
Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162(6):1239–1249
Jaswal S, Anand V, Ali SA, Jena MK, Kumar S, Kaushik JK, Mohanty AK (2021) TMT based deep proteome analysis of buffalo mammary epithelial cells and identification of novel protein signatures during lactogenic differentiation. FASEB J 35(6):e21621
Karplus M (2003) Molecular dynamics of biological macromolecules: a brief history and perspective. Biopolymers 68(3):350–358
Kaur G, Ali SA, Kumar S, Mohanty AK, Behare P (2017) Label-free quantitative proteomic analysis of Lactobacillus fermentum NCDC 400 during bile salt exposure. J Proteome 167:36–45
Kaur G, Poljak A, Ali SA, Zhong L, Raftery MJ, Sachdev P (2021a) Extending the depth of human plasma proteome coverage using simple fractionation techniques. J Proteome Res 20(2):1261–1279
Kaur H, Kalia M, Taneja N (2021b) Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis. Microb Pathog 152:104608
Kohavi R (1998) Glossary of terms. Special issue on applications of machine learning and the knowledge discovery process. Kluwer;30(271):127–132
Kumar R, Ali SA, Singh SK, Bhushan V, Mathur M, Jamwal S, Mohanty AK, Kaushik JK, Kumar S (2020) Antimicrobial peptides in farm animals: an updated review on its diversity, function, modes of action and therapeutic prospects. Vet Sci 7(4):206
Kumar R, Ali SA, Singh SK, Bhushan V, Kaushik JK, Mohanty AK, Kumar S (2021) Peptide profiling in cow urine reveals molecular signature of physiology-driven pathways and in-silico predicted bioactive properties. Sci Rep 11(1):1–6
Larsdotter S, Nostell K, von Euler H (2015) Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma. Vet J 205(2):313–316
Lee S, Ginese M, Beamer G, Danz HR, Girouard DJ, Chapman-Bonofiglio SP, Lee M, Hulverson MA, Choi R, Whitman GR, Ojo KK (2018) Therapeutic efficacy of bumped kinase inhibitor 1369 in a pig model of acute diarrhea caused by Cryptosporidium hominis. Antimicrob Agents Chemother 62(7):e00147-18
Li S, Su Z, Zhang C, Xu Z, Chang X, Zhu J, Xiao R, Li L, Zhou R (2018) Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein–protein interaction network. Genes Genomics 40(8):847–856
Lin X (2020) DeepGS: deep representation learning of graphs and sequences for drug-target binding affinity prediction. CoRR
Mahmud A, Khan MT, Iqbal A (2019) Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308. Microb Pathog 137:103731
Maziarka Ł, Danel T, Mucha S, Rataj K, Tabor J, Jastrzębski S (2020) Molecule attention transformer. CoRR
Mercado R, Rastemo T, Lindelöf E, Klambauer G, Engkvist O, Chen H, Bjerrum EJ (2020) Graph networks for molecular design. In: Machine learning: science and technology
Mohan J, Ali SA, Suvartan R, Kapila S, Sharma R, Tomar SK, Behare P, Yadav H (2018) Bioavailability of biotransformed zinc enriched dahi in wistar rats. Int J Probiotics Prebiotics 13(2–3):45
Mondal SI, Ferdous S, Jewel NA, Akter A, Mahmud Z, Islam MM, Afrin T, Karim N (2015) Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157: H7: an in silico approach. Adv Appl Bioinform Chem 8:49
Nataraj BH, Ali SA, Behare PV, Yadav H (2020) Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb Cell Factories 19(1):1–22
Noordik JH (ed) (2004) Cheminformatics developments: history, reviews and current research. IOS Press
Ozdemir S (2016) Principles of data science. Packt Publishing Ltd
Öztürk H, Özgür A, Ozkirimli E (2018) DeepDTA: deep drug–target binding affinity prediction. Bioinformatics 34(17):i821–i829
Parvege MM, Rahman M, Hossain MS (2014) Genome-wide analysis of Mycoplasma hominis for the identification of putative therapeutic targets. Drug Target Insights 8:DTI-S19728
Pham HN, Le TH (2019) Attention-based multi-input deep learning architecture for biological activity prediction: an application in EGFR inhibitors. CoRR
Pragya P, Kaur G, Ali SA, Bhatla S, Rawat P, Lule V, Kumar S, Mohanty AK, Behare P (2017) High-resolution mass spectrometry-based global proteomic analysis of probiotic strains Lactobacillus fermentum NCDC 400 and RS2. J Proteome 152:121–130
Radusky LG, Hassan SS, Lanzarotti E, Tiwari S, Jamal SB, Ali J, Ali A, Ferreira RS, Barh D, Silva A, Turjanski AG (2015) An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets. BMC Genomics 16(5):1–8
Rifaioglu AS, Nalbat E, Atalay V, Martin MJ, Cetin-Atalay R, Doğan T (2020) DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations. Chem Sci 11(9):2531–2557
Roskoski R Jr (2019) Properties of FDA-approved small molecule protein kinase inhibitors. Pharmacol Res 144:19–50
Roy J, Wycislo KL, Pondenis H, Fan TM, Das A (2017) Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin. PLoS One 12(9):e0183930
Sakharkar MK, Rajamanickam K, Chandra R, Khan HA, Alhomida AS, Yang J (2018) Identification of novel drug targets in bovine respiratory disease: an essential step in applying biotechnologic techniques to develop more effective therapeutic treatments. Drug Des Devel Ther 12:1135
Schaefer DA, Betzer DP, Smith KD, Millman ZG, Michalski HC, Menchaca SE, Zambriski JA, Ojo KK, Hulverson MA, Arnold SL, Rivas KL (2016) Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis. J Infect Dis 214(12):1856–1864
Shashikumar NG, Baithalu RK, Bathla S, Ali SA, Rawat P, Kumaresan A, Kumar S, Maharana BR, Singh G, Kumar DP, Singh SK (2018) Global proteomic analysis of water buffalo (Bubalus bubalis) saliva at different stages of estrous cycle using high throughput mass spectrometry. Theriogenology 110:52–60
Solanki V, Tiwari V (2018) Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Sci Rep 8(1):1–19
Ståhl N, Falkman G, Karlsson A, Mathiason G, Bostrom J (2019) Deep reinforcement learning for multiparameter optimization in de novo drug design. J Chem Inf Model 59(7):3166–3176
Tan MF, Zou G, Wei Y, Liu WQ, Li HQ, Hu Q, Zhang LS, Zhou R (2020) Protein–protein interaction network and potential drug target candidates of Streptococcus suis. J Appl Microbiol. https://doi.org/10.1111/jam.14950
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson I (2015) Tissue-based map of the human proteome. Science 347(6220):1260419
Vaibhao L, Kanchan M, Ali SA, Preeti R, Sudarshan K, Pradip B, Mohanty AK (2016) Evaluation of stationary phase and bile stress related protein spots in Lactobacillus fermentum NCDC 400 by 2-DE method. Indian J Dairy Sci 69(4):455–459
Van Voorhis WC, Doggett JS, Parsons M, Hulverson MA, Choi R, Arnold SL, Riggs MW, Hemphill A, Howe DK, Mealey RH, Lau AO (2017) Extended-spectrum antiprotozoal bumped kinase inhibitors: a review. Exp Parasitol 180:71–83
Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, Kaiser L, Polosukhin I (2017) Attention is all you need. CoRR
Wan F, Zhu Y, Hailin H, Dai A, Cai X, Chen L, Gong H, Xia T, Yang D, Wang M-W, Zeng J (2019) DeepCPI: a deep learning-based framework for large-scale in silico drug screening. Genomics Proteomics Bioinformatics 17(5):478–495
Wang R, Fang X, Yipin L, Yang C-Y, Wang S (2005) The PDBbind database: methodologies and updates. J Med Chem 48(12):4111–4119
Wang S, Zhenzhen D, Ding M, Zhao R, Rodriguez-Paton A, Song T (2020) LDCNN-DTI: a novel light deep convolutional neural network for drug-target interaction predictions. In: 2020 IEEE international conference on bioinformatics and biomedicine (BIBM). IEEE, pp 1132–1136
Zhou J, Li S, Liang H, Xiong H, Wang F, Xu T, Xiong H, Dou D (2020) Distance-aware molecule graph attention network for drug-target binding affinity prediction. CoRR
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ben Geoffrey, A.S., Virk, J.S., Mittal, D., Kaur, G., Ali, S.A. (2024). Data-Driven and Artificial Intelligence Approaches for System-Wide Prediction of the Drugable Proteome to Drug Discovery in Farm Animals. In: Kumar Yata, V., Mohanty, A.K., Lichtfouse, E. (eds) Sustainable Agriculture Reviews . Sustainable Agriculture Reviews, vol 62. Springer, Cham. https://doi.org/10.1007/978-3-031-54372-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-54372-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-54371-5
Online ISBN: 978-3-031-54372-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)